Malek-Adamian Elise, Patrascu Mihai Burai, Jana Sunit Kumar, Martínez-Montero Saúl, Moitessier Nicolas, Damha Masad J
Department of Chemistry , McGill University , 801 Sherbrooke Street West , Montreal , Quebec , Canada H3A 0B8.
J Org Chem. 2018 Sep 7;83(17):9839-9849. doi: 10.1021/acs.joc.8b01329. Epub 2018 Jul 17.
We report the first syntheses of three nucleoside analogues, namely, 2',4'-diOMe-rU, 2'-OMe,4'-F-rU, and 2'-F,4'-OMe-araU, via stereoselective introduction of fluorine or methoxy functionalities at the C4'-α-position of a 4',5'-olefinic intermediate. Conformational analyses of these nucleosides and comparison to other previously reported 2',4'-disubstituted nucleoside analogues make it possible to evaluate the effect of fluorine and methoxy substitution on the sugar pucker, as assessed by NMR, X-ray diffraction, and computational methods. We found that C4'-α-F/OMe substituents reinforce the C3'-endo ( north) conformation of 2'-OMe-rU. Furthermore, the predominant C2'-endo ( south/ east) conformation of 2'-F-araU switches to C3'-endo upon introduction of these substituents at C4'. The nucleoside analogues were incorporated into DNA and RNA oligonucleotides via standard phosphoramidite chemistry, and their effects on the thermal stability of homo- and heteroduplexes were assessed via UV thermal melting experiments. We found that 4'-substituents can modulate the binding affinity of the parent 2'-modified oligomers, inducing a mildly destabilizing or stabilizing effect depending on the duplex type. This study expands the spectrum of oligonucleotide modifications available for rational design of oligonucleotide therapeutics.
我们报道了三种核苷类似物的首次合成,即2',4'-二甲氧基尿苷、2'-甲氧基-4'-氟尿苷和2'-氟-4'-甲氧基阿糖胞苷,通过在4',5'-烯中间体的C4'-α位立体选择性引入氟或甲氧基官能团。对这些核苷进行构象分析,并与其他先前报道的2',4'-二取代核苷类似物进行比较,使得通过核磁共振、X射线衍射和计算方法评估氟和甲氧基取代对糖环构象的影响成为可能。我们发现,C4'-α-氟/甲氧基取代基增强了2'-甲氧基尿苷的C3'-内型(北)构象。此外,2'-氟阿糖胞苷的主要C2'-内型(南/东)构象在C4'引入这些取代基后转变为C3'-内型。通过标准亚磷酰胺化学方法将核苷类似物掺入DNA和RNA寡核苷酸中,并通过紫外热变性实验评估它们对同型和异型双链体热稳定性的影响。我们发现,4'-取代基可以调节母体2'-修饰寡聚物的结合亲和力,根据双链体类型诱导轻微的不稳定或稳定作用。这项研究扩展了可用于合理设计寡核苷酸治疗药物的寡核苷酸修饰谱。